Awarded
LOTE 4: Vacunas inactivadas producidas a partir de virus crecido en cultivos celulares de virus fraccionados o de antígenos de superficie (H y N), o análogas, de 15 microgramos de hemaglutinina de cada cepa incluida en la vacuna
Track this recordFree account — get alerted when a contract here runs out.
- Winners
- SEQIRUS SPAIN, S.L
- Contract value
- €15,400
- Bids received
- 1
- Published
- 4 Nov 2025
- Awarded
- 4 Nov 2025
- Contract start
- 4 Nov 2025
- Contract end
- 5 Nov 2026estimated
- Region
- Murcia